Safeguarding Health Through Diagnostics

Heidi and Scott Morey
Veterinarians Heidi Morey ’05 (CAHNR) and Scott Morey ’06 (CAHNR) with Jonathan XIV at Fenton River Veterinary Hospital in Tolland on June 21, 2017. (Peter Morenus/UConn Photo)

The Connecticut Veterinary Medical Diagnostic Laboratory (CVMDL) at UConn safeguards animal and human health. Faculty and staff fulfill their mission through veterinary diagnostic laboratory services, professional expertise, and collaboration with state and federal agencies to detect and monitor diseases important to animal and human health, as well as detecting newly emerging diseases.

CVMDL is committed to providing current, timely, and personalized expert service to our client veterinarians, animal owners, producers, academic collaborators, and partner agencies. The laboratory is housed within the Department of Pathobiology and Veterinary Science, and develops new approaches to disease identification, investigation, and prevention while educating students, including veterinarians, seeking advanced training in disease related studies.

CVMDL incorporates the land grant university mission of service, teaching, and research in its daily practices, and is the only laboratory in New England accredited by the American Association of Veterinary Laboratory Diagnosticians. Services offered include: histology, immunohistochemistry, mastitis, microbiology, molecular diagnostics, pathology, parasitology, serology, and virology.

“We send a lot of our clients to CVMDL for the necropsy service,” says Dr. Scott Morey ’06 (CAHNR) of Fenton River Veterinary Hospital in Tolland. “We want a necropsy done in the proper environment, where better diagnostic samples can be obtained and processed, as opposed to what we can collect in a field necropsy. Most of the time we’re mainly looking for infectious disease so we can change what happens for the other animals left on a farm.”

Necropsy services can also be used for small animals. Dr. Heidi Morey ’05 (CAHNR) handles the small animal end of the veterinary practice, while Scott primarily works with large animals. “We had one young dog die suddenly on a client, and CVMDL helped determine it was most likely a heart attack,” Heidi mentions.

“We do a surprising amount of chicken work,” Scott continues. “CVMDL completes efficient and timely necropsies on chickens. We also utilize them for rabies testing, and Caprine Arthritis Encephalitis (CAE) test for small ruminants. Clients who own sheep and goats want their animals to be CAE negative, and need proof of that. We send the samples to CVMDL.”

Tick testing is part of the molecular diagnostics section. A single infected deer tick can transmit anywhere from one to four illnesses simultaneously. CVMDL is the only laboratory in the state that will test a deer tick off humans or animals. CVMDL also tests other common species of ticks. The lab tests deer ticks for Borrelia burgdorferi, Anaplasma phagocytophilum, Babesia microti, and Borrelia miyamotoi. Dog ticks are tested for Francisella tularensis, Rickettsia rickettsia, Ehrlichiaspecies. Lonestar ticks are tested for Ehrlichiaspecies, Francisella tularensis, and Borrelia lonestari. Brown dog ticks are tested for Rickettsia rickettsiaand Ehrlichia species.

Residents, doctors, veterinarians, and public health officials utilize tick testing services to make proactive and informed decisions regarding human and animal health. In 2017, 397 ticks were tested.

Connecticut is home to a number of large dairy farms, and CVMDL provides mastitis testing and environmental pathogen testing, in addition to Brucellosis, Johnne’s, and other diseases. Rabies tests on animals that may have come in contact with a human are also sent to the Department of Public Health for confirmation testing. All other rabies testing in Connecticut is done at CVMDL.

The laboratory is on the frontlines of safeguarding animal and human health in Connecticut. Each case that arrives in Storrs is different, and provides the team at CVMDL with another opportunity to teach students and clients, develop new tests and procedures, and monitor disease and health issues.

Article by Stacey Stearns